Clinical Trial Update: Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By Surgery [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial investigating arsenic trioxide, temozolomide, and radiation therapy for malignant glioma post-surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain and Central Nervous System Tumors

Drugs mentioned

• Arsenic Trioxide (arsenic trioxide)
• Radiation therapy
• Temozolomide (Temozolomide)

Snippet

Sponsor: Northwestern University | Conditions: Brain and Central Nervous System Tumors | Phase 1, Phase 2 | Status: UNKNOWN